Over the past decade, there has been a rapid acceleration in the innovation of cancer diagnostics, treatments, and patient management. As a result of this acceleration, a tremendous amount of data is now generated. When this data is interconnected, it has the potential to provide oncology experts such as laboratory, Pharma company or academics with a comprehensive insight, enabling data-driven decision-making.
Uncover patterns, correlations, and trends that were previously unseen thanks to your integrated data and by leveraging advanced data analytics techniques, such as machine learning and predictive modeling, oncology experts can extract meaningful information.
Whether you are a research centre, a laboratory or a pharma company the initial question is still the same: What would you like to get from your data ?
Because there are a variety of data sources, OncoCDI value proposition is providing you with the best visualization wherein all real-data are integrated, curated, validated and thus reliable.
Clean, format and validate the reliability/accuracy of the data
Clean, format and validate the reliability/accuracy of the data
One of the key advantages of OncoCDI is its ability to interconnect your sample-based molecular and clinical data with the extensive OncoDNA’s knowledge base allowing to unlock the full potential of your data.
This integration allows you to tap into a vast database of scientific and clinical information, enhancing your understanding of the molecular profiles of your patients and their associated implications.
* From a global database of more than 120.000 samples
Company
OncoDNA S.A. (headquarters)
Rue Louis Breguet 1
BE-6041 Gosselies
Links
Support